141 related articles for article (PubMed ID: 16153303)
1. Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.
Richter TM; Tong BD; Scholnick SB
Cancer Cell Int; 2005 Sep; 5():29. PubMed ID: 16153303
[TBL] [Abstract][Full Text] [Related]
2. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.
Ma C; Quesnelle KM; Sparano A; Rao S; Park MS; Cohen MA; Wang Y; Samanta M; Kumar MS; Aziz MU; Naylor TL; Weber BL; Fakharzadeh SS; Weinstein GS; Vachani A; Feldman MD; Brose MS
Cancer Biol Ther; 2009 May; 8(10):907-16. PubMed ID: 19276661
[TBL] [Abstract][Full Text] [Related]
3. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma.
Jung AR; Eun YG; Lee YC; Noh JK; Kwon KH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545040
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.
Shull AY; Clendenning ML; Ghoshal-Gupta S; Farrell CL; Vangapandu HV; Dudas L; Wilkerson BJ; Buckhaults PJ
PLoS One; 2013; 8(3):e58731. PubMed ID: 23505554
[TBL] [Abstract][Full Text] [Related]
6.
Hu N; Wang C; Zhang T; Su H; Liu H; Yang HH; Giffen C; Hu Y; Taylor PR; Goldstein AM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291785
[TBL] [Abstract][Full Text] [Related]
7. Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma.
Kamal M; Shaaban AM; Zhang L; Walker C; Gray S; Thakker N; Toomes C; Speirs V; Bell SM
Breast Cancer Res Treat; 2010 Jun; 121(3):555-63. PubMed ID: 19669408
[TBL] [Abstract][Full Text] [Related]
8. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.
Ermis Akyuz E; Bell SM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553598
[TBL] [Abstract][Full Text] [Related]
9. Transcript map of the 8p23 putative tumor suppressor region.
Sun PC; Uppaluri R; Schmidt AP; Pashia ME; Quant EC; Sunwoo JB; Gollin SM; Scholnick SB
Genomics; 2001 Jul; 75(1-3):17-25. PubMed ID: 11472063
[TBL] [Abstract][Full Text] [Related]
10. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
11. Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion.
Kamal M; Holliday DL; Morrison EE; Speirs V; Toomes C; Bell SM
Oncol Rep; 2017 Jul; 38(1):283-292. PubMed ID: 28534981
[TBL] [Abstract][Full Text] [Related]
12. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza A; Bartoschek M; Gialeli C; Okroj M; Owen S; Jirström K; Orimo A; Jiang WG; Pietras K; Blom AM
Oncotarget; 2016 Nov; 7(47):76920-76933. PubMed ID: 27764775
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
14. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
16. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
[TBL] [Abstract][Full Text] [Related]
17. Identification of two new members of the CSMD gene family.
Lau WL; Scholnick SB
Genomics; 2003 Sep; 82(3):412-5. PubMed ID: 12906867
[TBL] [Abstract][Full Text] [Related]
18. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
Tanaka H; Shimada Y; Imamura M; Shibagaki I; Ishizaki K
Int J Cancer; 1997 Feb; 70(4):437-42. PubMed ID: 9033652
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
[TBL] [Abstract][Full Text] [Related]
20. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
